AlphaYou
Overview
Smart money at a glance
Filings to Oct 11, 2026Net selling: insiders sold $83K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$83K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 11- Open
- $3.62
- 52-wk high
- $7.13
- High
- $3.69
- 52-wk low
- $2.03
- Low
- $3.51
- Prev close
- $3.62
- Mkt cap
- $397.3M
- Volume
- 270.9K
- Fwd P/E
- 4.5x
- Beta
- 0.38
- P/B
- 207.7x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -3728.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about GALT filings
Are insiders buying or selling Galectin Therapeutics Inc (GALT) stock?
Net selling: insiders sold $83K and bought $0 of GALT stock on the open market in the 90 days to Oct 11, 2026, according to SEC Form 4 filings. $83K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Jamil, Khurram (Chief Medical Officer), who sold $83K. The latest filing was on Jul 16, 2026.
Which members of Congress have traded GALT recently?
None. No member of Congress disclosed a GALT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this GALT smart-money data?
This summary uses filings available on Oct 11, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- BR
BlackRock
$11.6M
added
What insiders are doing
How top traders are positioned
No tracked top-trader positions in GALT right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in $0.05 a share below what analysts expected.
Last report
Aug 13, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.09 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 13, 2026 | -$0.14 / -$0.09Alpha Vantage | -$0.05 miss | Unavailable | Unavailable |
| Mar 31, 2026 | May 15, 2026 | -$0.08 / -$0.06Alpha Vantage | -$0.02 miss | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 31, 2026 | -$0.08 / -$0.10Alpha Vantage | +20.00% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 14, 2025 | -$0.13 / -$0.11Alpha Vantage | -18.18% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 14, 2025 | -$0.12 / -$0.16Alpha Vantage | +25.00% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 15, 2025 | -$0.15 / -$0.11Alpha Vantage | -36.36% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 31, 2025 | -$0.19 / -$0.16Alpha Vantage | -18.75% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 14, 2024 | -$0.18 / -$0.20Alpha Vantage | +10.00% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 13, 2026, in 33 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Forward P/E
- 4.54
- Market cap
- $397M
Valuation
- P/B207.70
Quality
- Operating margin0.0%
- ROE-3728.0%
- ROA-64.2%
Growth
- Beta0.38
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace